Smith Susan Laura has filed 3 insider transactions across 1 company since January 2024.
Most recent transaction: a sale of 1682 shares of Y-mAbs Therapeutics, Inc. ($YMAB) on March 05, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Smith Susan Laura | SVP & CHIEF COMMERCIAL OFFICER | S | Common Stock | 1682 | $16.55 | 33,918.0000 | 43,645,388 | 4.72% | 0.00% |
| Jan. 18, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Smith Susan Laura | SVP & CHIEF COMMERCIAL OFFICER | A | Common Stock | 17800 | $0.00 | 35,600.0000 | 43,645,388 | 100.00% | 0.04% |
| Jan. 18, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Smith Susan Laura | SVP & CHIEF COMMERCIAL OFFICER | A | Employee Stock Option (right to buy) | 35700 | $0.00 | 35,700.0000 | 43,645,388 | 9999.99% | 0.08% |